GILEAD SCIENCES, INC.
GILD
46 insider filings · Latest: Jun 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 16 8:06 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $144.23 | $432.7K | — | View → |
| Mar 16, 2026 | Mar 16 8:06 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $144.23 | $432.7K | — | View → |
| Feb 27, 2026 | Mar 2 9:46 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 10,000 | $144.79 | $1.4M | 642,308(D) | View → |
| Feb 27, 2026 | Feb 27 9:10 PM | DANIEL O'DAY | Proposed Sale | 10,000 | $144.79 | $1.4M | — | View → |
| Feb 17, 2026 | Feb 18 10:22 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 28,000 | $154.44 | $4.3M | 120,288(D) | View → |
| Feb 17, 2026 | Feb 18 10:11 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $154.43 | $463.3K | 167,779(D) | View → |
| Feb 17, 2026 | Feb 17 9:07 PM | JOHANNA MERCIER | Proposed Sale | 28,000 | $154.44 | $4.3M | — | View → |
| Feb 17, 2026 | Feb 17 9:05 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $154.43 | $463.3K | — | View → |
| Feb 5, 2026 | Feb 6 9:22 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 115,640 | $150.00 | $17.3M | 613,912(D) | View → |
| Feb 5, 2026 | Feb 5 9:05 PM | DANIEL O'DAY | Proposed Sale | 115,640 | $150.00 | $17.3M | — | View → |
| Jan 28, 2026 | Jan 29 10:23 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 10,000 | $139.89 | $1.4M | 556,698(D) | View → |
| Jan 28, 2026 | Jan 28 10:02 PM | DANIEL O'DAY | Proposed Sale | 10,000 | $139.89 | $1.4M | — | View → |
| Jan 23, 2026 | Jan 27 12:29 AM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 115,640 | $135.00 | $15.6M | 566,698(D) | View → |
| Jan 23, 2026 | Jan 23 9:03 PM | DANIEL O'DAY | Proposed Sale | 115,640 | $135.00 | $15.6M | — | View → |
| Jan 22, 2026 | Jan 22 9:32 PM | DEBORAH TELMAN | Proposed Sale | 29,215 | $129.11 | $3.8M | — | View → |
| Jan 20, 2026 | Jan 21 9:26 PM | Jeffrey BluestoneDirector | Sale | 5,000 | $123.50 | $617.5K | 8,920(D) | View → |
| Jan 20, 2026 | Jan 20 9:01 PM | JEFFREY BLUESTONE | Proposed Sale | 5,000 | $123.50 | $617.5K | — | View → |
| Jan 15, 2026 | Jan 16 11:18 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $124.31 | $372.9K | 150,503(D) | View → |
| Jan 15, 2026 | Jan 16 11:10 PM | Johanna MercierChief Commercial Officer | Sale | 3,000 | $124.31 | $372.9K | 103,221(D) | View → |
| Jan 15, 2026 | Jan 15 9:02 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $124.31 | $372.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 12 8:37 PM | Erin BurkhartSVP, Controllership | Grant/Award | 7,810 | $148.56 | 5,455(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 20,026 | — | 68,044(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Grant/Award | 155,570 | $148.56 | 122,755(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Grant/Award | 39,890 | $148.56 | 31,475(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Option Exercise | 2,133 | — | 39,046(D) | View → |
| Feb 17, 2026 | Feb 18 10:22 PM | Johanna MercierChief Comm & Corp Aff Officer | Option Exercise | 25,000 | $66.64 | 48,110(D) | View → |
| Feb 5, 2026 | Feb 6 9:22 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 0(D) | View → |
| Jan 23, 2026 | Jan 27 12:29 AM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 115,640(D) | View → |
| Jan 20, 2026 | Jan 21 9:26 PM | Jeffrey BluestoneDirector | Option Exercise | 5,000 | $67.45 | 4,665(D) | View → |
← Previous
Page 2 of 2